Seelos Therapeutics Announces Positive Topline Data from the Open-Label Study of SLS-002 , Demonstrating a Significant Treatment Effect and a Well Tolerated Safety Profile for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Psychedelics Investing
FINAL DEADLINE NOTICE FROM FIRM THAT FILED CASE: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
BLU FINAL DEADLINE TOMORROW: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
SHRMF INVESTOR NOTICE: ROSEN, THE FIRST FILING FIRM, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SHRMF Psychedelics Investing
BLU FINAL DEADLINE ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - BLU Biotech Investing
BLU, NEPT & ROOT Final Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Biotech Investing
3-Day Deadline Alert: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors to Secure Counsel Before Important June 9 Deadline in First Filed Securities Class Action Commenced by the Firm - SHRMF Psychedelics Investing
BLU FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - BLU Biotech Investing
